Monthly Archives: January 2022
Assessing the Impact of Changes to the Rome IV Criteria for Clinical Practice in Irritable Bowel Syndrome.
Posted in News
Comments Off on Assessing the Impact of Changes to the Rome IV Criteria for Clinical Practice in Irritable Bowel Syndrome.
“A T.E.A.M. Approach to Diversity, Equity and Inclusion in Gastroenterology and Hepatology”
Posted in News
Comments Off on “A T.E.A.M. Approach to Diversity, Equity and Inclusion in Gastroenterology and Hepatology”
Predicting pancreatic cancer in the UK Biobank cohort using polygenic risk scores and diabetes mellitus.
Diabetes mellitus (DM) is known to be associated with Pancreatic ductal adenocarcinoma (PDAC), particularly, new-onset DM (NODM). Others have developed polygenic risk scores (PRS) associated with PDAC risk. We aimed to compare the performance of these … Continue reading
Posted in News
Comments Off on Predicting pancreatic cancer in the UK Biobank cohort using polygenic risk scores and diabetes mellitus.
Predicting pancreatic cancer in the UK Biobank cohort using polygenic risk scores and diabetes mellitus.
Diabetes mellitus (DM) is known to be associated with Pancreatic ductal adenocarcinoma (PDAC), particularly, new-onset DM (NODM). Others have developed polygenic risk scores (PRS) associated with PDAC risk. We aimed to compare the performance of these … Continue reading
Posted in News
Comments Off on Predicting pancreatic cancer in the UK Biobank cohort using polygenic risk scores and diabetes mellitus.
Treatment of Type 1 Diabetes by Microbiome Maintenance
Posted in News
Comments Off on Treatment of Type 1 Diabetes by Microbiome Maintenance
Treatment of Type 1 Diabetes by Microbiome Maintenance
Posted in News
Comments Off on Treatment of Type 1 Diabetes by Microbiome Maintenance
Author response to “MELD 3.0: The Model for End-stage Liver Disease Updated for the Modern Era”
Posted in News
Comments Off on Author response to “MELD 3.0: The Model for End-stage Liver Disease Updated for the Modern Era”
Covering the Cover
Patients with immune-mediated inflammatory diseases have a decreased response to messenger RNA COVID-19 vaccines. Continue reading
Posted in News
Comments Off on Covering the Cover